Eagle Pharmaceuticals, Inc. is a biotechnology pharmaceutical company, which focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. Its products include BYFAVO, PEMFEXY, RYANODEX, BENDEKA, and BELRAPZO. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Eagle Pharmaceuticals Inc market cap is $11.72M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Eagle Pharmaceuticals Inc 52 week high is $3.94 as of November 17, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Eagle Pharmaceuticals Inc 52 week low is $0.0011 as of November 17, 2026.
Eagle Pharmaceuticals Inc stock price today is $0.65.
Eagle Pharmaceuticals Inc stock price yesterday was $0.90.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Eagle Pharmaceuticals Inc 50-day moving average is $0.9946.